U.S. Beverage Stock News

Navitas Semiconductor unveiled a GaNFast powered 800 V to 6 V DC-DC power delivery board for AI data centers. The new architecture removes the traditional 48 V intermediate bus and is tailored for advanced NVIDIA AI infrastructure. The solution is being showcased at NVIDIA GTC 2026 and APEC 2026, highlighting real world validation with major industry partners. For investors watching NasdaqGM:NVTS, this announcement comes with the stock at $10.49, alongside a 25.2% return over the past week...

Cadence Design Systems recently expanded its collaboration with NVIDIA, integrating its chip and system design software with NVIDIA’s Grace CPUs, Blackwell GPUs and CUDA-X stack to power agentic AI design tools across electronic design, system design and life sciences. A distinctive aspect of this deal is Cadence’s plan to offer turnkey, physics-grounded AI design engines on its Millennium M2000 supercomputer, aiming to support autonomous, long-running engineering workflows in areas ranging...

In recent days, Transense Technologies plc announced it had secured a £2.99 million DriveSense contract, led by Cummins and part-funded by the UK Government, to develop next-generation smart electric drive systems for heavy-duty zero-emission vehicles, while Cummins also expanded its use of Laser Photonics’ CleanTech laser technology in engine maintenance. Together with Cummins’ data center-driven Power Systems strength and ongoing legal and competitive pressures, these developments...

If you are wondering whether Wendy's at around US$7.04 is a bargain or a value trap, this article will help you weigh what the current share price might be implying. The stock has faced heavy pressure, with returns of 3.2% over 7 days, 5.9% over 30 days, 13.8% year to date, 51.1% over the past year, and 60.3% and 57.6% over 3 and 5 years respectively. Recent attention on Wendy's has focused on broader questions around its brand position, store footprint and capital allocation. All of these...

In early March 2026, Veeva Systems reported fourth-quarter revenue of US$835.95 million and net income of US$244.2 million, alongside higher full-year revenue of US$3.20 billion and net income of US$908.91 million, and issued guidance calling for continued revenue growth in fiscal 2027. The company also highlighted expanding adoption of its Vault CRM platform and new wins such as AOP Health’s broad use of Veeva’s Development, Quality, Commercial, and Data Clouds, underlining its role as a...

In early March 2026, Simon Property Group reported record Q4 2025 results, with earnings and US$1.79 billion in revenue far above forecasts, launched a US$2.00 billion share repurchase program, and issued 2026 guidance pointing to higher funds from operations and net operating income. Management’s decision to pair a large buyback with plans for disciplined, accretive acquisitions and high-return redevelopments highlights a dual focus on returning capital while reinvesting for longer-term...

Stock performance context for CorMedix Without a specific news catalyst driving fresh headlines, CorMedix (CRMD) continues to draw attention as investors weigh its recent share performance in relation to its role in developing therapies for life threatening conditions. The stock last closed at US$6.54, with returns showing mixed momentum. It recorded a 1.4% gain over the past day, alongside a slight decline over the past week. See our latest analysis for CorMedix. Recent trading tells a mixed...

Board member Raymond A. Link recently sold nearly 25% of his nLIGHT (NasdaqGS:LASR) holdings. The sale came shortly after the company reported record revenue tied to defense focused products. The transaction followed a period of strong momentum in nLIGHT's aerospace and defense laser business. nLIGHT, listed on NasdaqGS:LASR, develops high power semiconductor and fiber lasers used in industrial, aerospace and defense applications. The business has been gaining attention for its defense...

Brown & Brown (BRO) has come onto investors’ radar after a recent share price move, with the stock up around 1% over the past month yet showing a decline over the past three months. See our latest analysis for Brown & Brown. That recent uptick sits within a mixed picture, with the 30 day share price return of 1.05% contrasting with a 90 day share price decline of 14.55% and a 1 year total shareholder return of 41.96% in the red. This suggests momentum has been fading after stronger multi year...

NeoGenomics (NEO) has drawn attention after its share price closed at $8.24, with recent returns showing pressure over the past month and past 3 months, prompting investors to reassess the cancer testing specialist. See our latest analysis for NeoGenomics. The recent 1 day share price return of 4.57% comes after a 30 day share price decline of 27.59% and a 1 year total shareholder return of 16.26% in the red. This indicates that pressure has been building for some time rather than momentum...

In early March 2026, Signet Jewelers presented at three major consumer and retail conferences hosted by Citi, Bank of America, and UBS in Florida and New York, sharing updates with institutional investors. These appearances came as the jeweler flagged pressure from higher gold and silver costs and slightly weaker same-store sales toward late 2025, prompting more cautious sentiment around its outlook. We’ll now explore how rising precious metal costs and softer same-store sales readings may...

Veracyte, Inc. recently appointed Kevin Haas, Ph.D., as its first Chief Development and Technology Officer, tasking him with overseeing end-to-end product development across diagnostic assays, software, bioinformatics and program management to support its expanding global portfolio of laboratory-developed tests and in vitro diagnostic products. This new role, filled by a leader with deep experience in automated lab technology, AI and genomics platforms, underscores Veracyte’s intent to more...

Earlier this month, Averna announced it had partnered with Curtiss-Wright to build five custom aerospace test systems that integrate secure data management and Curtiss-Wright's manufacturing execution systems for precision, safety-critical applications. This collaboration highlights how Curtiss-Wright is leaning on specialist automation expertise to enhance its production capabilities for Tier 1 aerospace programs and demanding defense customers. Next, we'll examine how this new aerospace...

In recent days, The Times’ publication of extracts that prompted a high-profile response from the Duke and Duchess of Sussex concentrated reader attention on royal coverage, while Google faced renewed calls from European publishers including News Corp for EU regulators to conclude a long-running antitrust probe and impose penalties. Together, this surge in engagement around royal news and News Corp’s prominent role in pushing EU scrutiny of Google underscores how its UK media reach and...

Earlier in March 2026, Illumina announced a collaboration with Veritas Genetics Powered By Fuze Health to integrate whole-genome sequencing into preventive healthcare via insurance plans, while also advancing a large-scale multiomic drug discovery effort through its expanded Alliance for Genomic Discovery with Nashville Biosciences and new pharma partners. Together, these initiatives aim to make clinical-grade genomics and proteomics part of routine care and research, creating a large,...

Why Ensign Group is on investors’ radar today Ensign Group (ENSG) has drawn attention after recent share price moves, with the stock showing mixed short term performance alongside stronger gains over the past 3 months and year. See our latest analysis for Ensign Group. At the current share price of $209.46, Ensign Group’s recent 1 day and 1 month share price returns have softened slightly. However, the 90 day share price return of 19.45% and 1 year total shareholder return of 61.61% suggest...

Solaris Energy Infrastructure recently closed two deals that will add about 900 MW of new natural gas-fueled turbine capacity by 2029, including the acquisition of Genco Power Solutions and the purchase of 30 turbine delivery slots, funded through a mix of cash, new shares, assumed debt, and a new US$300 million credit facility. This expansion program will lift Solaris’s total operated power generation capacity to roughly 3,100 MW by 2029 and commits the company to approximately US$935...

Spyre Therapeutics recently reported that it has completed recruitment for the rheumatoid arthritis (RA) sub-study of its SKYWAY Phase 2 basket trial evaluating SPY072, an extended half-life TL1A-targeting antibody, and has accelerated the expected timing of topline proof-of-concept data to the third quarter of 2026 for RA and the fourth quarter of 2026 for psoriatic arthritis and axial spondyloarthritis. This progress underscores how basket and platform trial designs could speed clinical...

Recent performance and business profile Figure Technology Solutions (FIGR) has drawn attention after a mixed period for the stock, with a slight gain over the past month contrasting with a negative move over the past 3 months and year to date. The Reno based financial technology company focuses on blockchain based products for lending, trading and investing in the United States. The company reported revenue of US$432.055m and net income of US$133.858m in its latest figures. See our latest...

What Fidelis Insurance Holdings’ completed buyback means for shareholders Fidelis Insurance Holdings (FIHL) has just wrapped up a sizeable buyback, repurchasing 18,823,327 shares for US$351.4 million, equal to 18.24% of its share base under a program launched in August 2025. From October 1, 2025 to March 3, 2026 alone, the company bought back 16,988,264 shares, or 16.49% of its stock, at a time when the shares most recently closed at US$18.95. See our latest analysis for Fidelis Insurance...

Pharvaris recently reported that a company-sponsored real-world, mixed methods study on patient experiences during acute hereditary angioedema (HAE) attacks and related clinical endpoints has been published in Clinical Reviews in Allergy & Immunology, supporting the use of several patient-reported outcome (PRO) tools in ongoing and future deucrictibant trials. The study’s finding that patients view even small early improvements, captured by the End of Progression™ endpoint, as meaningfully...

In recent weeks, Sesame Workshop filed a lawsuit against United Parks & Resorts, alleging unpaid royalties and contract breaches tied to Sesame Street–branded attractions, while SeaWorld Orlando continued building its new SeaQuest: Legends of the Deep ride amid heightened geopolitical and oil market uncertainty. At the same time, institutional investor Melqart Asset Management disclosed a new stake in the company, highlighting how legal risks, new attraction investments, and shifting...

Earlier this month, DICK'S Sporting Goods reported fourth-quarter and full-year 2025 results showing sales rising to US$6,226.05 million for the quarter and US$17.22 billion for the year, while net income and diluted EPS from continuing operations declined year over year, and it issued full-year 2026 guidance calling for US$22.10–US$22.40 billion in net sales and US$13.70–US$14.70 in EPS. The company also raised its quarterly dividend by 3% to US$1.25 per share, authorized an annualized...

Extreme Networks (EXTR) shares are in focus after Cellhub, a healthcare technology aggregator and Primary Agent for T-Mobile, agreed to use the company’s AI-powered networking in its Hospitals Without Walls connectivity program. See our latest analysis for Extreme Networks. The recent Cellhub agreement comes as Extreme Networks trades at US$14.83, with a 7 day share price return of 5.70%, a 90 day share price return of 11.67%, and a 3 year total shareholder return of 17.70%. If you are...